BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cyberonics Inc. (CYBX) to Participate in Upcoming Investor Conferences


5/28/2013 7:37:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOUSTON, May 28, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.

Greg Browne, Cyberonics' Chief Financial Officer, will present at the Jefferies 2013 Global Healthcare Conference in New York on Thursday, June 6, 2013 at 9:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 6, 2013.

Mr. Browne, along with Milton Morris, Ph.D., Cyberonics' Senior Vice President, Research and Development, and Sherrie Perkins, Cyberonics' Vice President of Marketing and New Business Development, will present at the William Blair 33rd Annual Growth Stock Conference in Chicago on Tuesday, June 11, 2013 at 10:10 AM Central Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 11, 2013.

In addition, Mr. Browne and Ms. Perkins will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes on June 12, 2013 at 1:20 PM Pacific Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 12, 2013.

Finally, Mr. Browne, along with Peter Donato, Cyberonics' Corporate Controller, will participate in the Northcoast Research 2013 Healthcare Forum in New York on Tuesday, June 18, 2013. The format for this conference is one-on-one or small group meetings. No formal presentation will be made, and the group meetings will not be webcast.

About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Contact Information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262 / Fax: (281) 218-9332
ir@cyberonics.com

SOURCE Cyberonics, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES